Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the Cardio‐Oncology Study Group of the Heart Failure Association and the Cardio‐Oncology Council of the European Society of Cardiology
2020 | journal article. A publication with affiliation to the University of Göttingen.
Jump to: Cite & Linked | Documents & Media | Details | Version history
Cite this publication
Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the Cardio‐Oncology Study Group of the Heart Failure Association and the Cardio‐Oncology Council of the European Society of Cardiology
Pudil, R.; Mueller, C. ; Čelutkienė, J.; Henriksen, P. A.; Lenihan, D.; Dent, S. & Barac, A. et al. (2020)
European Journal of Heart Failure, 22(11) pp. 1966-1983. DOI: https://doi.org/10.1002/ejhf.2017
Documents & Media
Details
- Authors
- Pudil, Radek; Mueller, Christian ; Čelutkienė, Jelena; Henriksen, Peter A.; Lenihan, Dan; Dent, Susan; Barac, Ana; Stanway, Susanna; Moslehi, Javid; Suter, Thomas M.; Ky, Bonnie; Štěrba, Martin; Cardinale, Daniela; Cohen‐Solal, Alain; Tocchetti, Carlo Gabriele; Farmakis, Dimitrios; Bergler‐Klein, Jutta; Anker, Markus S.; Von Haehling, Stephan ; Belenkov, Yury; Iakobishvili, Zaza; Maack, Christoph; Ciardiello, Fortunato; Ruschitzka, Frank; Coats, Andrew J.S.; Seferovic, Petar; Lainscak, Mitja; Piepoli, Massimo F.; Chioncel, Ovidiu; Bax, Jereon; Hulot, Jean‐Sebastien; Skouri, Hadi; Hägler‐Laube, Eva Simona; Asteggiano, Riccardo; Fernandez, Teresa Lopez; Boer, Rudolf A.; Lyon, Alexander R.
- Issue Date
- 2020
- Journal
- European Journal of Heart Failure
- ISSN
- 1388-9842
- eISSN
- 1879-0844
- Language
- English
